Citius Oncology, Inc.
CTOR · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $311 | $67 | $82 | $99 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $4 | $4 | $4 | $4 |
| Enterprise Value | $315 | $70 | $86 | $103 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5 | -$7 | -$6 | -$7 |
| % Margin | – | – | – | – |
| Net Income | -$5 | -$8 | -$7 | -$7 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.075 | -0.11 | -0.093 | -0.098 |
| % Growth | 31.8% | -18.2% | 4.7% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |